openPR Logo
Press release

US Transdermal Patch Market US Transdermal Sales Report 2020

07-11-2017 12:25 PM CET | Health & Medicine

Press release from: Kuick Resarch

US Transdermal Patch Market US Transdermal Sales Report 2020

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Report Table of Contents

1. Introduction to Transdermal Patch

2. Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch

3. Why There Exist Need for Transdermal Patches?

4. Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of Transdermal Patch
4.3 Mechanism of Motion Sickness, Nicotine & Female Contraceptive Transdermal Patch

5. Transdermal Patch v/s Traditional Drug Delivery Methods

6. US Transdermal Patch Market Overview
6.1 Current Market Scenario
6.2 US Transdermal Patch Clinical Pipeline Overview

7. Generic & Branded Transdermal Patches

8. Value Chain Analysis for Transdermal Patch Market
8.1 Research & Development
8.2 Manufacturing
8.3 Marketing & Distribution
8.4 Price to End User


9. US Transdermal Patch Contract Manufacturing Organization (CMO)

10. US Transdermal Patch Market Opportunity Assessment
10.1 Parkinson’s Disease
10.2 Alzheimer's Disease
10.3 Female Contraceptive
10.4 Nicotine Replacement Therapy
10.5 Insulin
10.6 Vaccine

11. US Transdermal Patch Market Dynamics
11.1 Favorable Market Parameters
11.2 Commercialization Challenges

12. US Transdermal Patch Market Future Prospects

13. US Transdermal Patch Clinical Pipeline by Company, Indication & Phase
13.1 Research
13.2 Preclinical
13.3 Phase-I
13.4 Phase-I/II
13.5 Phase-II
13.6 Phase-II/III
13.7 Phase-III
13.8 Preregistration
13.9 Registered

14. Marketed Transdermal Patch Clinical Insight by Company & Indication


15. Discontinued & No Development Reported in US Transdermal Patch Clinical Pipeline
15.1 No Development Reported
15.2 Discontinued
15.3 Marketed Withdrawal

16. Competitive Landscape
16.1 3M Pharmaceuticals
16.2 Acrux
16.3 Agile Therapeutics
16.4 Allergan
16.5 ANI Pharmaceuticals
16.6 Antares Pharma
16.7 Bayer HealthCare Pharmaceuticals
16.8 Corium International
16.9 Chase Pharmaceuticals
16.10 DURECT Corporation
16.11 Endo Pharmaceuticals
16.12 Fempharm
16.13 Hisamitsu Pharmaceutical
16.14 Immune Pharmaceuticals
16.15 Imprimis Pharmaceuticals
16.16 Ipsen Bioscience
16.17 Johnson & Johnson
16.18 LaSalle Laboratories
16.19 Lavipharm-increase
16.20 MINRAD International
16.21 NeurogesX
16.22 Noven Pharmaceuticals
16.23 NuPathe
16.24 Nuvo Research
16.25 Novartis
16.26 Pain Therapeutics
16.27 ProStrakan
16.28 Purdue Pharma
16.29 Sanofi
16.30 Scilex Pharmaceuticals
16.31 Senju Pharmaceutical
16.32 Somerset Pharmaceuticals
16.33 Teikoku Seiyaku
16.34 Therapeutic Discovery Corporation
16.35 Transdermal Delivery Solutions Corp
16.36 UCB
16.37 Xel Pharmaceuticals
16.38 Zosano Pharma

Download Report: https://www.kuickresearch.com/report-US-Transdermal-Patch-Market-Outlook-2020.php

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Transdermal Patch Market US Transdermal Sales Report 2020 here

News-ID: 618892 • Views: 206

More Releases from Kuick Resarch

Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy
Global Cell Therapy Market Stem Cell Therapy Market Size Sales Growth Clinical T …
Global Cell Therapy Market Size Sales Opportunity To Surpass USD 40 Billion By 2027 Says Kuick Research Report Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027 "Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market: > USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Cell Therapy Price & Product Insight By Region/Country • Clinical
Global Small Molecule Targeted Cancer Drug Market Size Sales To Reach US$ 130 Bi …
"Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Small Molecule Cancer Drug Market: > US$ 125 Billion by 2026 • USA Dominates Global Small Molecule Cancer Drug Market: >50% Share • Number of Small Molecule Cancer Drugs In Clinical Trials: >2500 Drugs • Small Molecule Cancer Drugs Dosage, Sales, Price & Patent Insight: 175 Drugs • Small Molecule Drug Insight by Cancer • Clinical Trials Insight
GCC Clinical Trial Market Outlook Insight 2025
"GCC Clinical Trial Market Outlook 2025" Report Highlights: • GCC Clinical Trial Market Opportunity: >US$ 500 Million • GCC Disease Prevalence & Statistics • Saudi Arabia Dominating GCC Clinical Trial Landscape: > 500 Trials • Clinical Trials for Cancer in GCC: > 120 Trials • Guidelines For Conducting Clinical Trials by Country • Ongoing Clinical Trials Insight by Country Download Report: https://www.kuickresearch.com/report-report-report-report-report-report-report-report-gcc-clinical-trial-market-size-number--data-regulation-registration Table of Contents 1. GCC Clinical Market Regional Insights 2. GCC Clinical Trial Market Dynamics 2.1 Driving Forces for GCC Clinical Trial

All 5 Releases


More Releases for Transdermal

Fentanyl Transdermal Patches Market – Comprehensive Survey 2025
This research study is one of the most detailed and accurate ones that solely focus on the global Fentanyl Transdermal Patches market. It sheds light on critical factors that impact the growth of the global Fentanyl Transdermal Patches market on several fronts. Market participants can use the report to gain sound understanding of the competitive landscape and strategies adopted by leading players of the global Fentanyl Transdermal Patches market. The
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
US Transdermal Patch Market Outlook 2020 Report
“US Transdermal Patch Market Outlook 2020” Report Highlights: * US Transdermal Patch Market Overview * Generic & Branded Transdermal Patches * US Transdermal Patch Market: Value Chain Analysis * US Transdermal Patch Contract Manufacturing Organization * US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase * US Transdermal Patch Clinical Pipeline: 55 Patches * Majority Patches in Preclinical Phase: 23 Patches * Marketed Transdermal Patch Clinical Insight by Company & Indication * Marketed Transdermal Patches in
Therapeutic Landscape of Transdermal Drug Delivery Pipeline
Summary The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3090629-transdermal-drug-delivery-medical-devices-pipeline-assessment-2018 Scope -
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
Transdermal Drug Delivery Systems Market – Trends 2025
A transdermal drug delivery systems (TDDS) is a medicated adhesive bandage or a patch that is stuck onto the skin to deliver a dose of drug through the skin and in the bloodstream. This patch promotes faster healing of injuries on the body, delivers a steady infusion of the drug over a time period and increases the therapeutic value of drugs by avoiding problem associated with drug. This is a